Mouse OX40/TNFRSF4 Antibody Summary
Val20-Pro211
Accession # P47741
Applications
The ED50 for this effect is typically 0.4 - 1.2 μg/mL.
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Reconstitution Calculator
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: OX40
OX40, also known as CD134, was originally identified as an activated rat CD4+ T cell-surface antigen that is recognized by the monoclonal antibody MRC OX40. It is a member of the tumor necrosis factor receptor superfamily (TNFRSF) and has been designated TNFRSF4. Mouse OX40 cDNA encodes a 256 amino acid (aa) residues type I transmembrane precursor protein with a putative 19 aa signal peptide, a 192 aa extracellular domain containing 4 TNFR-cysteine rich repeats, a 25 aa transmembrane domain and a 36 aa cytoplasmic region. A naturally occurring soluble OX40 has also been identified in human serum. Mouse OX40 shares approximately 63% and 90% aa sequence identity with its human and rat counterparts, respectively. OX40 is a T cell activation antigen that is expressed primarily on activated CD4+ T cells, but is also expressed on activated human and mouse CD8+ T cells. The ligand of OX40 is OX40 ligand (OX40L), also known as gp34, a type II transmembrane glycoprotein belonging to the TNF superfamily. OX40L is expressed on activated B cells, T cells, dendritic cells and endothelial cells. Ligation of OX40 on T cells by OX40L or an agonistic antibody can promote clonal expansion, long-term T cell survival, and enhance memory T cell development. In vivo, blockade of OX40/OX40L interaction has been useful for treating autoimmune disease and graft-versus-host disease in animal models. Activation of OX40 has also been utilized to enhance the potency of vaccines and augment anti-tumor immunity (1-9).
- Paterson, D.J. et al. (1987) Mol. Immunol. 24:1281.
- Mallett, S. et al. (1990) EMBO J. 9:1063.
- Calderhead, D.M. et al. (1993) J. Immunol. 151:5261.
- Baum, P.R. et al. (1994) EMBO J. 13:3992.
- Gramaglia, I. et al. (1998) J. Immunol. 161:6510.
- Bansal-Pakala, P. et al. (2001) Nature Medicine 7:907.
- Rogers, P.R. et al. (2001) Immunity 15:445.
- Taylor, L. and H.J. Schwarz (2001) Immunol. Methods 255:67.
- Weinberg, A.D. (2002) Trends in Immunol. 23:102.
Product Datasheets
Citations for Mouse OX40/TNFRSF4 Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
2
Citations: Showing 1 - 2
Filter your results:
Filter by:
-
Type 2 innate lymphoid cells drive CD4+ Th2 cell responses.
Authors: Mirchandani, Ananda S, Besnard, Anne-Gae, Yip, Edwin, Scott, Charlott, Bain, Calum C, Cerovic, Vuk, Salmond, Robert J, Liew, Foo Y
J Immunol, 2014-01-27;192(5):2442-8.
Species: Mouse
Sample Types: Whole Cells
Applications: Neutralization -
OX40 complexes with phosphoinositide 3-kinase and protein kinase B (PKB) to augment TCR-dependent PKB signaling.
Authors: So T, Choi H, Croft M
J. Immunol., 2011-02-02;186(6):3547-55.
Species: Mouse
Sample Types: Cell Lysates
Applications: Western Blot
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Mouse OX40/TNFRSF4 Antibody
There are currently no reviews for this product. Be the first to review Mouse OX40/TNFRSF4 Antibody and earn rewards!
Have you used Mouse OX40/TNFRSF4 Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image